ThETA: transcriptome-driven efficacy estimates for gene-based TArget discovery.


Journal

Bioinformatics (Oxford, England)
ISSN: 1367-4811
Titre abrégé: Bioinformatics
Pays: England
ID NLM: 9808944

Informations de publication

Date de publication:
15 08 2020
Historique:
received: 29 11 2019
revised: 23 04 2020
accepted: 16 05 2020
pubmed: 22 5 2020
medline: 2 2 2021
entrez: 22 5 2020
Statut: ppublish

Résumé

Estimating efficacy of gene-target-disease associations is a fundamental step in drug discovery. An important data source for this laborious task is RNA expression, which can provide gene-disease associations on the basis of expression fold change and statistical significance. However, the simply use of the log-fold change can lead to numerous false-positive associations. On the other hand, more sophisticated methods that utilize gene co-expression networks do not consider tissue specificity. Here, we introduce Transcriptome-driven Efficacy estimates for gene-based TArget discovery (ThETA), an R package that enables non-expert users to use novel efficacy scoring methods for drug-target discovery. In particular, ThETA allows users to search for gene perturbation (therapeutics) that reverse disease-gene expression and genes that are closely related to disease-genes in tissue-specific networks. ThETA also provides functions to integrate efficacy evaluations obtained with different approaches and to build an overall efficacy score, which can be used to identify and prioritize gene(target)-disease associations. Finally, ThETA implements visualizations to show tissue-specific interconnections between target and disease-genes, and to indicate biological annotations associated with the top selected genes. ThETA is freely available for academic use at https://github.com/vittoriofortino84/ThETA. vittorio.fortino@uef.fi. Supplementary data are available at Bioinformatics online.

Identifiants

pubmed: 32437556
pii: 5841656
doi: 10.1093/bioinformatics/btaa518
pmc: PMC7390989
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

4214-4216

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press.

Références

Sci Rep. 2019 May 10;9(1):7233
pubmed: 31076736
Nucleic Acids Res. 2017 Jan 4;45(D1):D833-D839
pubmed: 27924018
Nucleic Acids Res. 2019 Jan 8;47(D1):D948-D954
pubmed: 30247620
Nucleic Acids Res. 2002 Jan 1;30(1):412-5
pubmed: 11752352
Nucleic Acids Res. 2006 Jan 1;34(Database issue):D668-72
pubmed: 16381955
Nucleic Acids Res. 2017 Jan 4;45(D1):D985-D994
pubmed: 27899665
Sci Rep. 2019 Jul 8;9(1):9852
pubmed: 31285471
Nucleic Acids Res. 2016 Jul 8;44(W1):W90-7
pubmed: 27141961
Nucleic Acids Res. 2000 Jan 1;28(1):27-30
pubmed: 10592173
Science. 2015 May 8;348(6235):648-60
pubmed: 25954001
Genome Med. 2014 Aug 26;6(8):64
pubmed: 25246945
Nucleic Acids Res. 2017 Jan 4;45(D1):D995-D1002
pubmed: 27903890
Nucleic Acids Res. 2019 Jan 8;47(D1):D590-D595
pubmed: 30321428
Nucleic Acids Res. 2013 Jan;41(Database issue):D808-15
pubmed: 23203871
Nat Genet. 2000 May;25(1):25-9
pubmed: 10802651
Nucleic Acids Res. 2020 Jan 8;48(D1):D1031-D1041
pubmed: 31691823
Nucleic Acids Res. 2020 Jan 8;48(D1):D498-D503
pubmed: 31691815
Nucleic Acids Res. 2018 Jan 4;46(D1):D649-D655
pubmed: 29145629
Nucleic Acids Res. 2019 Jan 8;47(D1):D330-D338
pubmed: 30395331
Nucleic Acids Res. 2018 Jan 4;46(D1):D1074-D1082
pubmed: 29126136
Nucleic Acids Res. 2017 Jan 4;45(D1):D972-D978
pubmed: 27651457

Auteurs

Mario Failli (M)

Institute of Biomedicine, University of Eastern Finland, Kuopio 70210, Finland.
Department of Chemical, Materials and Industrial Engineering, University of Naples 'Federico II', Naples 80125, Italy.

Jussi Paananen (J)

Institute of Biomedicine, University of Eastern Finland, Kuopio 70210, Finland.
Blueprint Genetics Ltd, Finland.

Vittorio Fortino (V)

Institute of Biomedicine, University of Eastern Finland, Kuopio 70210, Finland.
Blueprint Genetics Ltd, Finland.

Articles similaires

Selecting optimal software code descriptors-The case of Java.

Yegor Bugayenko, Zamira Kholmatova, Artem Kruglov et al.
1.00
Software Algorithms Programming Languages

Exploring blood-brain barrier passage using atomic weighted vector and machine learning.

Yoan Martínez-López, Paulina Phoobane, Yanaima Jauriga et al.
1.00
Blood-Brain Barrier Machine Learning Humans Support Vector Machine Software
Arabidopsis Arabidopsis Proteins Osmotic Pressure Cytoplasm RNA, Messenger
Cephalometry Humans Anatomic Landmarks Software Internet

Classifications MeSH